Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon.
Sivabaskari PasupathyRosanna TavellaChristopher ZeitzSuzanne Melissa EdwardsMatthew WorthleyMargaret ArstallJohn F BeltramePublished in: Journal of clinical medicine (2024)
Zibotentan improved the frequency of spontaneous angina episodes and reduced sublingual nitrate consumption in patients unresponsive to standard anti-anginal therapy.
Keyphrases
- coronary artery disease
- end stage renal disease
- coronary artery
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- heart failure
- peritoneal dialysis
- stem cells
- drinking water
- percutaneous coronary intervention
- acute coronary syndrome
- left ventricular
- mesenchymal stem cells
- allergic rhinitis
- smoking cessation